Lv1
90 积分 2022-10-28 加入
Reduction−Alkylation Strategies for the Modification of Specific Monoclonal Antibody Disulfides
4天前
已完结
The present and future of bispecific antibodies for cancer therapy
4天前
已完结
Continuous Processing for Manufacturing of Antibody–Drug Conjugates (ADCs)
27天前
已完结
Antibody-Mediated Delivery of BRM/BRG1 Protein Degraders Affords Strong Antitumor Efficacy in Multiple BRM-Dependent Non-Small Cell Lung Cancer Xenograft Models
1个月前
已完结
Discovery of ABBV-154, an anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody-Drug Conjugate (iADC)
2个月前
已完结
Monoclonal antibody and protein therapeutic formulations for subcutaneous delivery: high-concentration, low-volume vs. low-concentration, high-volume
2个月前
已完结
Agitation-Induced Aggregation of Lysine- And Interchain Cysteine-Linked Antibody-Drug Conjugates
2个月前
已完结
In-depth characterization analysis of a bispecific antibody acidic charge variant
2个月前
已完结
Process characterization and Design Space definition
2个月前
已完结
Stabilization of cysteine-linked antibody drug conjugates with N-aryl maleimides
3个月前
已完结
皖公网安备34019202002308
